Pyruvate dehydrogenase kinase 4 (PDK4) is an inhibitor of mitochondrial pyruvate dehydrogenase, and inhibiting PDK4 reversed the resistance of HCC stem cells to sorafenib or cisplatin (Figure 3) [73]. The gene discussed is PDK4; the disease is hepatocellular carcinoma.